Anavex Life Sciences
AVXL
AVXL
182 hedge funds and large institutions have $270M invested in Anavex Life Sciences in 2025 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 58 increasing their positions, 44 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
182
Holders Change
+14
Holders Change %
+8.33%
% of All Funds
2.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
40
Increased
58
Reduced
44
Closed
25
Calls
$14.7M
Puts
$8.92M
Net Calls
+$5.76M
Net Calls Change
-$378K
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$6.88M |
| 2 |
LPL Financial
San Diego,
California
|
+$3.88M |
| 3 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$2.35M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.9M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.62M |
Top Sellers
| 1 |
SC
Sculptor Capital
New York
|
-$3.97M |
| 2 |
EP
Essential Planning
Portsmouth,
New Hampshire
|
-$3.25M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.98M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.06M |
| 5 |
Renaissance Technologies
New York
|
-$1.71M |